Name	Gene(s)	Protein change	Condition(s)	Clinical significance (Last reviewed)	Review status	Accession	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	dbSNP ID	Canonical SPDI	
Single allele	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|SNORD115-1|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|PWAR1|PWAR4|PWARSN|PWRN1|PWRN2|SNORD116-1|PWAR6		Chromosome 15q11-q13 duplication syndrome	Pathogenic(Last reviewed: Oct 16, 2018)	criteria provided, single submitter	VCV000666599	15	23810928 - 28544664			666599	654159		
NM_019066.5(MAGEL2):c.509_510delinsTG (p.Ala170Val)	MAGEL2	A170V	Schaaf-Yang syndrome	Uncertain significance(Last reviewed: Jul 3, 2020)	criteria provided, single submitter	VCV001184373	15	23892380 - 23892381	15	23647233 - 23647234	1184373	1174176		NC_000015.10:23647232:GG:CA
NM_019066.5(MAGEL2):c.1145_1147dup (p.Gln383_Ala384insArg)	MAGEL2		Schaaf-Yang syndrome	Uncertain significance(Last reviewed: Mar 5, 2019)	criteria provided, single submitter	VCV001028137	15	23891742 - 23891743	15	23646595 - 23646596	1028137	1017877		NC_000015.10:23646595:GCC:GCCGCC
NM_019066.5(MAGEL2):c.188dup (p.Ala64fs)	MAGEL2	A64fs	Schaaf-Yang syndrome	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, single submitter	VCV000692038	15	23892701 - 23892702	15	23647554 - 23647555	692038	679792	rs1595334203	NC_000015.10:23647554:GG:GGG
NM_019066.5(MAGEL2):c.2170_2232dup (p.Ser724_Ala744dup)	MAGEL2		Schaaf-Yang syndrome	Uncertain significance(Last reviewed: Jan 9, 2019)	criteria provided, single submitter	VCV000599395	15	23890657 - 23890658	15	23645510 - 23645511	599395	590731	rs1566784117	
NM_019066.5(MAGEL2):c.1996dup (p.Gln666fs)	MAGEL2	Q666fs	Schaaf-Yang syndrome|Inborn genetic diseases|not provided	Pathogenic(Last reviewed: May 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000190122	15	23890893 - 23890894	15	23645746 - 23645747	190122	187954	rs770374710	NC_000015.10:23645746:GGGGGGG:GGGGGGGG
NC_000023.10:g.(?_153287264)_(153363188_?)dup	MECP2		Mental retardation, X-linked, syndromic 13|Rett syndrome|Angelman syndrome	Pathogenic(Last reviewed: Oct 27, 2016)	criteria provided, single submitter	VCV000417368	X	153287264 - 153363188			417368	404014		
NM_002487.3(NDN):c.472dup (p.Thr158fs)	NDN	T158fs	Prader-Willi syndrome	Uncertain significance(Last reviewed: Oct 17, 2018)	criteria provided, single submitter	VCV000930829	15	23931892 - 23931893	15	23686745 - 23686746	930829	919558		NC_000015.10:23686745:TT:TTT
Single allele	PWAR4|LOC645202|SNORD115-1|GOLGA8S|APBA2|GABRA5|PWAR5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|TJP1|UBE3A|MKRN3|SNURF|CYFIP1|FAM189A1|NPAP1|LINC02249|SNORD115-2|SNORD116-26|SNORD116-27|SNORD115-6|SNORD115-7|MAGEL2|NSMCE3|ATP10A|NIPA2|TUBGCP5|NIPA1|PWAR1|GOLGA6L2|GOLGA6L1|GOLGA8J|GOLGA8T|GOLGA8M|SNORD115@|SNORD116@|SNORD116-19|LOC112272579|LOC112272580|GOLGA8G|SNORD108|LOC112272581|GOLGA6L7|SNORD116-20|SNORD116-21|SNORD115-17|SNORD115-18|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-40|ATP10A-DT|LOC112272575|LOC112272578|CHRFAM7A|HERC2|SNORD107|LOC100132202|LOC102723623|SNHG14|SNORD115-3|SNORD115-4|SNORD115-5|SNORD109B|SNORD116-1|SNORD116-2|SNORD116-3|SNORD116-24|SNORD116-25|MIR4508|MIR4509-3|MIR4509-2|MIR4715|SNORD116-30|SNORD115-46|GOLGA8F|TRE-TTC2-2|PWRN4|SNORD115-19|SNORD115-20|SNORD115-41|SNORD115-42|SNORD115-43|PWAR6|SNORD116-7|SNORD115-44|SNORD116-28|PWRN3|GABRG3-AS1|MIR4509-1|SNORD109A|LINC02250|SNORD116-29|SNORD115-48|SNORD115-24|SNORD115-27|SNORD115-28|SNORD115-45|SNORD115-47|LINC02346|LOC100130111|PWRN1|PWRN2|SNORD115-21|SNORD115-22|SNORD115-8|SNORD115-9|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-29|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-23|SNORD115-25|SNORD115-26|SNORD116-8|SNORD116-9|SNORD116-10|SNORD116-11|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD115-34|SNORD115-35|SNORD116-22|SNORD116-23|SNORD64|PWARSN|LINC00929		Chromosome 15q11-q13 duplication syndrome	Pathogenic(Last reviewed: Jun 5, 2020)	criteria provided, single submitter	VCV001098669			15	22804175 - 30375696	1098669	1087289		
NC_000015.10:g.(?_24566038)_(25781223_?)dup	PWAR5|UBE3A|IPW|PWAR6|SNRPN|SNORD116-1|PWAR1|PWARSN|PWAR4|ATP10A|SNORD115-1|NPAP1|PWRN1|SNURF		Angelman syndrome	Likely pathogenic(Last reviewed: Feb 26, 2019)	criteria provided, single submitter	VCV000832161	15	24811185 - 26026370			832161	820665		
NM_130839.5(UBE3A):c.2515_2531dup (p.Leu846fs)	SNHG14|UBE3A	L409fs, L429fs, L771fs, L774fs, L787fs, L794fs, L826fs, L846fs, L849fs	Angelman syndrome	Pathogenic(Last reviewed: Jul 12, 2020)	criteria provided, single submitter	VCV001073548	15	25584371 - 25584372	15	25339224 - 25339225	1073548	1063216		NC_000015.10:25339224:AGCACATTAAAGCAAGTA:AGCACATTAAAGCAAGTAGCACATTAAAGCAAGTA
NC_000015.9:g.(?_25584264)_(25620930_?)dup	SNHG14|UBE3A		Angelman syndrome	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000583426	15	25584264 - 25620930	15	25339117 - 25375783	583426	568557		
NM_130839.5(UBE3A):c.1678_1699delinsT (p.Gln560_Val567delinsPhe)	SNHG14|UBE3A		Angelman syndrome	Uncertain significance(Last reviewed: Aug 13, 2019)	criteria provided, single submitter	VCV000571267	15	25605584 - 25605605	15	25360437 - 25360458	571267	569216	rs1566912450	NC_000015.10:25360436:CACCTCCCTCATCAACTCCTTG:A
NM_130839.5(UBE3A):c.2355-6_2355-5insTAAT	SNHG14|UBE3A		Angelman syndrome	Likely benign(Last reviewed: Oct 3, 2017)	criteria provided, single submitter	VCV000528368	15	25585380 - 25585381	15	25340233 - 25340234	528368	528969	rs1555380917	NC_000015.10:25340233::ATTA
NC_000015.9:g.(?_25584264)_(25654274_?)dup	SNHG14|UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, single submitter	VCV000458664			15	25339117 - 25409127	458664	464765		
NC_000015.9:g.(?_25582396)_(25650653_?)dup	SNHG14|UBE3A		Angelman syndrome	Uncertain significance(Last reviewed: Apr 5, 2016)	criteria provided, single submitter	VCV000417431	15	25582396 - 25650653	15	25337249 - 25405506	417431	400846		
NM_130839.5(UBE3A):c.2607dup (p.Gly870fs)	SNHG14|UBE3A	G795fs, G818fs, G870fs, G433fs, G453fs, G798fs, G850fs, G873fs, G811fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000212536	15	25584295 - 25584296	15	25339148 - 25339149	212536	208160	rs797046088	NC_000015.10:25339148:AAA:AAAA
NM_130839.5(UBE3A):c.2563_2567dup (p.Lys856fs)	SNHG14|UBE3A	K419fs, K804fs, K781fs, K784fs, K856fs, K859fs, K439fs, K836fs, K797fs	Angelman syndrome	Pathogenic(Last reviewed: Oct 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000212535	15	25584335 - 25584336	15	25339188 - 25339189	212535	208161	rs1555379800	NC_000015.10:25339188:TTAAGTT:TTAAGTTAAGTT
NM_130839.5(UBE3A):c.2562dup (p.Leu855fs)	SNHG14|UBE3A	L418fs, L783fs, L796fs, L835fs, L438fs, L803fs, L855fs, L780fs, L858fs	Angelman syndrome	Pathogenic(Last reviewed: Jul 11, 2014)	criteria provided, single submitter	VCV000212534	15	25584340 - 25584341	15	25339193 - 25339194	212534	208163	rs797046087	NC_000015.10:25339193:TTTTT:TTTTTT
NM_130839.5(UBE3A):c.2523_2566dup (p.Lys856fs)	SNHG14|UBE3A	K781fs, K856fs, K859fs, K419fs, K784fs, K797fs, K836fs, K439fs, K804fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000212533	15	25584336 - 25584337	15	25339189 - 25339190	212533	208162	rs587781230	NC_000015.10:25339189:TAAGTTTTTCTTTGCTTGAGTATTCCGGAAGTAAAAGCACATTA:TAAGTTTTTCTTTGCTTGAGTATTCCGGAAGTAAAAGCACATTATAAGTTTTTCTTTGCTTGAGTATTCCGGAAGTAAAAGCACATTA
NM_130839.5(UBE3A):c.2397_2400dup (p.Leu801fs)	SNHG14|UBE3A	L726fs, L742fs, L364fs, L781fs, L384fs, L729fs, L749fs, L804fs, L801fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000212532	15	25585329 - 25585330	15	25340182 - 25340183	212532	208164	rs797046086	NC_000015.10:25340182:TCTTT:TCTTTCTTT
NM_130839.5(UBE3A):c.2238dup (p.Phe747fs)	SNHG14|UBE3A	F672fs, F310fs, F330fs, F747fs, F750fs, F688fs, F727fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000212531	15	25599716 - 25599717	15	25354569 - 25354570	212531	208165	rs797046085	NC_000015.10:25354569:T:TT
NM_130839.5(UBE3A):c.62+1_62+2insAA	SNHG14|UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000212530	15	25650606 - 25650607	15	25405459 - 25405460	212530	208169	rs797046084	NC_000015.10:25405459::TT
NM_130839.5(UBE3A):c.2499-37dup	SNHG14|UBE3A		Angelman syndrome	Uncertain significance(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000156127	15	25584440 - 25584441	15	25339293 - 25339294	156127	165927	rs587782913	NC_000015.10:25339293:T:TT
NM_130839.5(UBE3A):c.2547_2567dup (p.Lys856_Glu857insAsnSerSerLysGluLysLeu)	SNHG14|UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155993	15	25584335 - 25584336	15	25339188 - 25339189	155993	165797	rs587781240	NC_000015.10:25339188:TTAAGTTTTTCTTTGCTTGAGT:TTAAGTTTTTCTTTGCTTGAGTTAAGTTTTTCTTTGCTTGAGT
NM_130839.5(UBE3A):c.2563_2566dup (p.Lys856delinsThrTer)	SNHG14|UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155983	15	25584336 - 25584337	15	25339189 - 25339190	155983	165787	rs398124440	NC_000015.10:25339189:TAAGT:TAAGTAAGT
NM_130839.5(UBE3A):c.2557_2560dup (p.Lys854fs)	SNHG14|UBE3A	K437fs, K779fs, K854fs, K795fs, K834fs, K857fs, K417fs, K782fs, K802fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155982	15	25584342 - 25584343	15	25339195 - 25339196	155982	165786	rs587781229	NC_000015.10:25339195:TTTCTTT:TTTCTTTCTTT
NM_130839.5(UBE3A):c.2523_2581dup (p.Lys861delinsIleMetCysPheTyrPheArgAsnThrGlnAlaLysLysAsnLeuLysArgAspCysTer)	SNHG14|UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155977	15	25584321 - 25584322	15	25339174 - 25339175	155977	165781	rs1555379745	
NM_130839.5(UBE3A):c.2349dup (p.Ile784fs)	SNHG14|UBE3A	I347fs, I709fs, I725fs, I764fs, I732fs, I787fs, I367fs, I712fs, I784fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155974	15	25599504 - 25599505	15	25354357 - 25354358	155974	165778	rs587781223	NC_000015.10:25354357:C:CC
NM_130839.5(UBE3A):c.2307_2311dup (p.Thr771fs)	SNHG14|UBE3A	T719fs, T771fs, T334fs, T354fs, T696fs, T699fs, T712fs, T751fs, T774fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155973	15	25599542 - 25599543	15	25354395 - 25354396	155973	165777	rs587781222	NC_000015.10:25354395:TAGTTT:TAGTTTAGTTT
NM_130839.5(UBE3A):c.2230_2234dup (p.Tyr745Ter)	SNHG14|UBE3A	Y328*, Y725*, Y745*, Y748*, Y308*, Y670*, Y686*	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155967	15	25599720 - 25599721	15	25354573 - 25354574	155967	165771	rs587781216	NC_000015.10:25354573:TACTTTA:TACTTTACTTTA
NM_130839.5(UBE3A):c.2162_2163insTATT (p.Lys721fs)	SNHG14|UBE3A	K304fs, K721fs, K284fs, K646fs, K724fs, K662fs, K701fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155966	15	25599792 - 25599793	15	25354645 - 25354646	155966	165770	rs587781215	NC_000015.10:25354645::AATA
NM_130839.5(UBE3A):c.2017dup (p.Met673fs)	SNHG14|UBE3A	M673fs, M676fs, M614fs, M236fs, M256fs, M653fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155963	15	25601145 - 25601146	15	25355998 - 25355999	155963	165767	rs587781212	NC_000015.10:25355998:T:TT
NM_130839.5(UBE3A):c.1699_1702dup (p.Ser568fs)	SNHG14|UBE3A	S571fs, S509fs, S151fs, S548fs, S131fs, S568fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155958	15	25605580 - 25605581	15	25360433 - 25360434	155958	165762	rs587781207	NC_000015.10:25360433:AAACA:AAACAAACA
NM_130839.5(UBE3A):c.1668dup (p.Glu557Ter)	SNHG14|UBE3A	E537*, E557*, E560*, E498*, E120*, E140*	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155957	15	25605614 - 25605615	15	25360467 - 25360468	155957	165761	rs587781206	NC_000015.10:25360467:AAA:AAAA
NM_130839.5(UBE3A):c.1631dup (p.Asn544fs)	SNHG14|UBE3A	N107fs, N485fs, N127fs, N544fs, N547fs, N524fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155956	15	25605651 - 25605652	15	25360504 - 25360505	155956	165760	rs587781205	NC_000015.10:25360504:TTTT:TTTTT
NM_130839.5(UBE3A):c.1597dup (p.Ala533fs)	SNHG14|UBE3A	A474fs, A533fs, A536fs, A513fs	Angelman syndrome	Pathogenic(Last reviewed: Dec 10, 2014)	criteria provided, single submitter	VCV000155955	15	25615723 - 25615724	15	25370576 - 25370577	155955	165759	rs587781204	NC_000015.10:25370576:C:CC
NM_130839.5(UBE3A):c.1415dup (p.Ser473fs)	SNHG14|UBE3A	S414fs, S473fs, S476fs, S453fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155950	15	25615905 - 25615906	15	25370758 - 25370759	155950	165754	rs587781199	NC_000015.10:25370758:AA:AAA
NM_130839.5(UBE3A):c.1136dup (p.Asn379fs)	SNHG14|UBE3A	N359fs, N379fs, N320fs, N382fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155945	15	25616184 - 25616185	15	25371037 - 25371038	155945	165749	rs587781194	NC_000015.10:25371037:TTT:TTTT
NM_130839.5(UBE3A):c.1127dup (p.Tyr376Ter)	SNHG14|UBE3A	Y317*, Y356*, Y376*, Y379*	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155944	15	25616193 - 25616194	15	25371046 - 25371047	155944	165748	rs587781193	NC_000015.10:25371046:T:TT
NM_130839.5(UBE3A):c.640dup (p.Ser214fs)	SNHG14|UBE3A	S194fs, S217fs, S155fs, S214fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000136196	15	25616680 - 25616681	15	25371533 - 25371534	136196	139900	rs587780574	NC_000015.10:25371533:T:TT
NM_130839.5(UBE3A):c.463dup (p.Ser155fs)	SNHG14|UBE3A	S155fs, S135fs, S158fs, S96fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000136194	15	25616857 - 25616858	15	25371710 - 25371711	136194	139898	rs587780572	NC_000015.10:25371710:AAAAAA:AAAAAAA
NM_130839.5(UBE3A):c.335dup (p.Lys113fs)	SNHG14|UBE3A	K54fs, K116fs, K93fs, K113fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000136190	15	25620637 - 25620638	15	25375490 - 25375491	136190	139894	rs587780568	NC_000015.10:25375490:TT:TTT
NM_130839.5(UBE3A):c.259_262dup (p.Gly88fs)	SNHG14|UBE3A	G68fs, G88fs, G91fs, G29fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000136188	15	25620710 - 25620711	15	25375563 - 25375564	136188	139892	rs587780566	NC_000015.10:25375563:CTTTCTT:CTTTCTTTCTT
NM_130839.5(UBE3A):c.2124+9_2124+10insTT	UBE3A|SNHG14		Angelman syndrome	Likely benign(Last reviewed: Sep 17, 2020)	criteria provided, single submitter	VCV001126495	15	25601029 - 25601030	15	25355882 - 25355883	1126495	1124155		NC_000015.10:25355882:A:AAA
NC_000015.9:g.(?_25584273)_(25650609_?)dup	UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Oct 3, 2020)	criteria provided, single submitter	VCV001075074	15	25584273 - 25650609			1075074	1057670		
NM_130839.5(UBE3A):c.2600_2604dup (p.Phe869fs)	UBE3A|SNHG14	F452fs, F797fs, F817fs, F869fs, F872fs, F794fs, F810fs, F849fs, F432fs	Angelman syndrome	Likely pathogenic(Last reviewed: Nov 14, 2019)	criteria provided, single submitter	VCV000961399	15	25584298 - 25584299	15	25339151 - 25339152	961399	948780		NC_000015.10:25339151:TCCTTT:TCCTTTCCTTT
NC_000015.10:g.(?_25339137)_(25405462_?)dup	UBE3A		Angelman syndrome	Likely pathogenic(Last reviewed: Jun 18, 2019)	criteria provided, single submitter	VCV000831131	15	25584284 - 25650609			831131	820669		
NC_000015.10:g.(?_25339117)_(25360547_?)dup	UBE3A		Angelman syndrome	Uncertain significance(Last reviewed: May 21, 2019)	criteria provided, single submitter	VCV000830404	15	25584264 - 25605694			830404	820666		
NM_130839.5(UBE3A):c.2517_2553dup (p.Lys852delinsLeuLeuTer)	UBE3A|SNHG14		Angelman syndrome	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803055	15	25584349 - 25584350	15	25339202 - 25339203	803055	791432	rs1595362860	NC_000015.10:25339202:GCTTGAGTATTCCGGAAGTAAAAGCACATTAAAGCAAG:GCTTGAGTATTCCGGAAGTAAAAGCACATTAAAGCAAGCTTGAGTATTCCGGAAGTAAAAGCACATTAAAGCAAG
NM_130839.5(UBE3A):c.1244_1253dup (p.Gly419fs)	UBE3A|SNHG14	G399fs, G422fs, G360fs, G419fs	Angelman syndrome|not provided	Pathogenic(Last reviewed: Mar 14, 2016)	criteria provided, single submitter	VCV000280389	15	25616067 - 25616068	15	25370920 - 25370921	280389	264716	rs886041603	NC_000015.10:25370920:TTCTTGTTTCTTCTT:TTCTTGTTTCTTCTTGTTTCTTCTT
UBE3A, 15-BP DEL/7-BP INS, NT3240	UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Jan 1, 2010)	no assertion criteria provided	VCV000030204					30204	39160		
UBE3A, 4-BP DUP, EX10, GAGG	UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Jun 15, 2004)	no assertion criteria provided	VCV000007972					7972	23011		
UBE3A, 5-BP DUP	UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Jan 1, 1997)	no assertion criteria provided	VCV000007963					7963	23002		
